AR029189A1 - Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento - Google Patents

Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento

Info

Publication number
AR029189A1
AR029189A1 ARP000105742A ARP000105742A AR029189A1 AR 029189 A1 AR029189 A1 AR 029189A1 AR P000105742 A ARP000105742 A AR P000105742A AR P000105742 A ARP000105742 A AR P000105742A AR 029189 A1 AR029189 A1 AR 029189A1
Authority
AR
Argentina
Prior art keywords
separately
inhibitor
phosphodiesterase
preparation
inflammatory
Prior art date
Application number
ARP000105742A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR029189A1 publication Critical patent/AR029189A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP000105742A 1999-11-02 2000-10-31 Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento AR029189A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
AR029189A1 true AR029189A1 (es) 2003-06-18

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105742A AR029189A1 (es) 1999-11-02 2000-10-31 Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento

Country Status (29)

Country Link
EP (1) EP1225866A4 (zh)
JP (1) JP2003513028A (zh)
KR (1) KR20020057988A (zh)
CN (1) CN1387404A (zh)
AP (1) AP2002002496A0 (zh)
AR (1) AR029189A1 (zh)
AU (1) AU1357501A (zh)
BG (1) BG106748A (zh)
BR (1) BR0015270A (zh)
CA (1) CA2388333A1 (zh)
CO (1) CO5261512A1 (zh)
CZ (1) CZ20021512A3 (zh)
DZ (1) DZ3225A1 (zh)
EA (1) EA200200518A1 (zh)
EC (1) ECSP003747A (zh)
HK (1) HK1049107A1 (zh)
HU (1) HUP0203152A3 (zh)
IL (1) IL149367A0 (zh)
MA (1) MA26841A1 (zh)
MX (1) MXPA02004350A (zh)
NO (1) NO20022057L (zh)
OA (1) OA12076A (zh)
PE (1) PE20011005A1 (zh)
PL (1) PL355261A1 (zh)
SK (1) SK7592002A3 (zh)
TR (1) TR200201211T2 (zh)
TW (1) TWI242431B (zh)
WO (1) WO2001032127A2 (zh)
ZA (1) ZA200203435B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496607C (zh) * 2001-09-19 2009-06-10 尼科梅德有限责任公司 Nsaid与pde-4抑制剂的并用药物
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US20060199789A1 (en) * 2003-03-31 2006-09-07 Kyowa Hakko Kogyo Co., Ltd. medical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
JP2003513028A (ja) 2003-04-08
SK7592002A3 (en) 2002-11-06
CZ20021512A3 (cs) 2003-04-16
HUP0203152A3 (en) 2004-06-28
DZ3225A1 (fr) 2001-05-10
EA200200518A1 (ru) 2002-10-31
MXPA02004350A (es) 2002-11-07
TWI242431B (en) 2005-11-01
ECSP003747A (es) 2002-05-23
CO5261512A1 (es) 2003-03-31
WO2001032127A3 (en) 2001-12-06
KR20020057988A (ko) 2002-07-12
BG106748A (en) 2003-02-28
NO20022057L (no) 2002-06-27
MA26841A1 (fr) 2004-12-20
PL355261A1 (en) 2004-04-05
CN1387404A (zh) 2002-12-25
IL149367A0 (en) 2002-11-10
WO2001032127A2 (en) 2001-05-10
EP1225866A2 (en) 2002-07-31
ZA200203435B (en) 2003-06-25
CA2388333A1 (en) 2001-05-10
AU1357501A (en) 2001-05-14
HUP0203152A2 (hu) 2003-01-28
TR200201211T2 (tr) 2002-08-21
AP2002002496A0 (en) 2002-06-30
NO20022057D0 (no) 2002-04-30
EP1225866A4 (en) 2004-04-21
BR0015270A (pt) 2002-06-18
PE20011005A1 (es) 2001-09-28
OA12076A (en) 2006-05-04
HK1049107A1 (zh) 2003-05-02

Similar Documents

Publication Publication Date Title
DE60114571D1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
BR0005299A (pt) Compostos para o tratamento de disfução sexual feminina
ID29181A (id) Kombinasi formoterol dan garam tiotropium
AR037255A1 (es) Composiciones farmaceuticas que contienen oxibutinina
ES2190692B1 (es) Formulacion farmaceutica de amoxicilina y clavulanato de potasio.
YU106192A (sh) Nova kombinacija bronhodilatatora i steroidnog antiinflamatornog leka za lečenje respiratornih poremećaja
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
AR013614A1 (es) Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
AR029189A1 (es) Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
BR9908617A (pt) Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica.
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
AR026197A1 (es) Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina
BR0007613A (pt) Aplicação de imidazo[1,5-a]-pirido[3,2-e]-pirazinonascomo medicamento
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
CR8584A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
PT927031E (pt) Composicao farmaceutica que contem nimesulide para administracao por via oral
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
WO2001001995A3 (en) Method for treatment of asthma syndrome
BRPI0509305A (pt) uso de um sensibilizador insulìnico, composição farmecêutica, e , kit

Legal Events

Date Code Title Description
FA Abandonment or withdrawal